This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Vitamin D deficiency

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Vitamin D and its active metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D) have classical actions on calcium balance and bone metabolism (1).

  • Insufficient 1,25(OH)2D leads to inadequate absorption of calcium and phosphate which results in secondary hyperparathyroidism and lack of new bone mineralisation - rickets in children and osteomalacia in adults.
  • A consensus statement representing the unified views of a number of organisations (the British Association of Dermatologists, Cancer Research UK, Diabetes UK, the Multiple Sclerosis Society, the National Heart Forum, the National Osteoporosis Society and the Primary Care Dermatology Society), states that the evidence suggesting that vitamin D might protect against cancer, heart disease, diabetes, multiple sclerosis and other chronic diseases is still inconclusive. Furthermore, there is no standard definition of what constitutes an optimal level of vitamin D (2).

Vitamin D deficiency is common in northern UK.

  • In a recent cross-sectional study (3), results showed that vitamin D status varied among different ethnic groups and by season and geographical area within the UK:
    • vitamin D deficiency was more common in winter and spring, and its prevalence was higher in the northern UK than the southern UK
    • male sex, abnormal BMI, Asian and black ethnic backgrounds, and tobacco smoking were associated with higher odds of vitamin D deficiency
    • taking vitamin D supplements and drinking alcohol were associated with lower odds of vitamin D deficiency
    • these results provide some evidence supporting the Public Health England recommendation for taking vitamin D supplementation in winter and for people with black or Asian ethnic background
  • Prevalence of vitamin D deficiency in commonly encountered clinical patient populations is as follows (4):
    • nursing home or house bound residents (mean age 81 years): 25-50%
    • elderly ambulatory women aged >80 years: 44%
    • women with osteoporosis aged 70-79 years: 30%
    • patients with hip fractures (mean age 77 years): 23%
    • African American women aged 15-49 years: 42%
    • adult hospitalised patients (mean age 62 years): 57%

Vitamin D deficiency and chronic obstructive pulmonary disease (COPD).

  • Men with COPD were more likely to be vitamin D deficient than those with normal lung function (5).
    • Vitamin D deficiency is associated with increased all-cause mortality in older men with no lung impairment as well as in those with restrictive or obstructive lung impairment.

Opinions on optimal vitamin D serum concentrations in adults vary (1).

  • According to the Endocrine Society Task Force guidelines vitamin D deficiency is defined as a serum 25-hydroxycholecalciferol (25OHD) <50 nmol/L but advocated that 25OHD concentration should exceed 75 nmol/L, to maximise the effect of vitamin D on calcium, bone and muscle metabolism.
  • The UK Royal Osteoporosis Society recommends the following vitamin D thresholds for UK practitioners in respect to bone health:
    • serum 25OHD < 25 nmol/L is deficient
    • serum 25OHD of 25–50 nmol/L may be inadequate in some people
    • serum 25OHD > 50 nmol/L is sufficient for almost the whole population (1)

References


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.